Architecture that Might Have Contributed to Disease PreventionEMERGING INFECTIOUS DISEASESIF6.62024-06-010OAAI
COVID-19 Vaccine Initiation and Dose Completion During the SARS-CoV-2 Delta Variant Surge in the United States, December 2020-October 2021PUBLIC HEALTH REPORTSIF2.52022-09-210OAAI
Using a Cloud-Based Machine Learning Classification Tree Analysis to Understand the Demographic Characteristics Associated With COVID-19 Booster Vaccination Among Adults in the United StatesOPEN FORUM INFECTIOUS DISEASESIF3.82022-09-014OAAI
Factors Associated with Delayed or Missed Second-Dose mRNA COVID-19 Vaccination among Persons ≥12 Years of Age, United StatesEMERGING INFECTIOUS DISEASESIF6.62022-08-014OAAI
Of Those We Have Lost and Those Who Have Saved So Many OthersEMERGING INFECTIOUS DISEASESIF6.62022-07-010OAAI
Disparities in First Dose COVID-19 Vaccination Coverage among Children 5-11 Years of Age, United StatesEMERGING INFECTIOUS DISEASESIF6.62022-05-0124OAAI
When a Touch of Gold Was Used to Heal the King's EvilEMERGING INFECTIOUS DISEASESIF6.62022-03-010OAAI
Association of Tumor Necrosis Factor α Inhibitor Use with Diagnostic Features and Mortality of Tuberculosis in the United States, 2010-2017OPEN FORUM INFECTIOUS DISEASESIF3.82021-12-221OAAI
ATS/CDC/ERS/IDSA Clinical Practice Guidelines for Treatment of Drug-Resistant Tuberculosis: A Two-edged Sword? ReplyAMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINEIF19.42020-09-010OAAI
The Concept of the Crown and Its Potential Role in the Downfall of CoronavirusEMERGING INFECTIOUS DISEASESIF6.62020-09-017OAAI
Essential Components of a Public Health Tuberculosis Prevention, Control, and Elimination Program: Recommendations of the Advisory Council for the Elimination of Tuberculosis and the National Tuberculosis Controllers AssociationMMWR RECOMMENDATIONS AND REPORTSIF60.12020-07-3142OAAI
Confusion in the Genesis of Art and Disease-Charles Laval, Paul Gauguin, and TuberculosisEMERGING INFECTIOUS DISEASESIF6.62020-03-010OAAI
Treatment of Drug-Resistant Tuberculosis An Official ATS/CDC/ERS/IDSA Clinical Practice GuidelineAMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINEIF19.42019-11-15287OAAI
Bedaquiline for the Treatment of Multidrug-resistant Tuberculosis in the United StatesCLINICAL INFECTIOUS DISEASESIF7.32019-09-2636OAAI
Rifampin-resistant Tuberculosis in the United States, 1998-2014CLINICAL INFECTIOUS DISEASESIF7.32019-06-2214OAAI
Tuberculosis Surveillance and Control, Puerto Rico, 1898-2015EMERGING INFECTIOUS DISEASESIF6.62019-03-014OAAI
Trench Conflict with Combatants and Infectious DiseaseEMERGING INFECTIOUS DISEASESIF6.62018-11-011OAAI